Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07498322 · ClinicalTrials.gov registry record · NA
Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System
A NA study, sponsored by University of Illinois at Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 271,031
- Enrollment target
NCT07498322 is a NA study that has not yet begun recruiting, run by University of Illinois at Chicago. The registered enrollment target is 271,031 participants.
The verdict
NCT07498322, a NA study, has not yet begun recruiting, sponsored by University of Illinois at Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 271,031 participants
- Enrollment target
Study Summary
This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to answer are: 1. Does the C-DOSETaP System increase screening for patients with OUD; 2. Does the C-DOSETaP System improve continuity of health care for patients with OUD; 3. Does the C-DOSETaP System increase use of medications for opioid use disorder; and 4. Does the C-DOSETaP System reduce the number of opioid-related deaths in the neighborhoods served.
Interventions
- OTHER OUD screening
- OTHER MOUD
- OTHER Continuity of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271,031 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07498322
The ClinicalTrials.gov registry entry for NCT07498322 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 271,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which OUD screening is the first listed.
NCT07498322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07498322 about?
NCT07498322 is a clinical study titled "Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System". This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to answer are: 1. Does t...
What is the current status of trial NCT07498322?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 271,031 participants. The study started on 2026-06-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07498322?
The interventions under investigation include: OUD screening (OTHER), MOUD (OTHER), Continuity of care (OTHER).
Who is sponsoring clinical trial NCT07498322?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.